Genentech’s Risdiplam Meets Primary Endpoint in Pivotal SUNFISH Trial in People With Type 2 or …

Neuroscience is a major focus of research and development at Genentech and Roche. The company's goal is to develop treatment options based on …

Link to Full Article: Read Here